Polaryx Therapeutics, Inc. Other operating expenses decreased by 61.2% to $1.96M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase suggests unexpected operational costs or one-time charges that may negatively impact operating margins.
Other operating expenses capture miscellaneous costs incurred during the normal course of business that are not categori...
Varies widely by company based on accounting policies and the frequency of non-recurring events.
other_operating_expenses| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $5.05M | $1.96M |
| QoQ Change | — | -61.2% |
| YoY Change | — | -61.2% |